 |
 |
Listfriends: I recently posted news of the results of the recent meeting of the scientific review committee of the International Research Grants Program of the Parkinson's Disease Foundation, out of which awards (for one year, averaging $35,000) were made to 17 scientists (and teams), chosen from 70 applications, for a total of more than $600,000. Now that we have notified all candidates of the outcome, I can publish this list of those who were successful: Anders Bjorklund, M.D., University of Lund, Sweden Delivery of L-dopa and GDNF in Animal Models of Parkinson's disease via Recombinant Adeno-Associated Virus Mediated Gene. Jiang-Fan Chen, M.D., Massachusetts General Hospital, Boston, MA Assessing A2a Adenosine Antagonists as Novel Antiparkinsonian Agents Using an A2a Receptor Knock-out Model Robert Chen, M.A., MBChir, MSc, FRCPC, The Toronto Hospital, Toronto, Canada Physiologic Effects of Deep-Brain Stimulation in Patients with Parkinson's Disease Marie-Francoise Chesselet, M.D., Ph.D., UCLA School of Medicine, Los Angeles, CA Mechanisms of MPTP-Induced DNA Damage: Studies in Genetically Engineered Mice Richard A. Flavell, Ph.D., Yale Univetrsity School of Medicine, New Haven, CT The Role of JNK3 Signalling Pathway in Neuronal Death: Practical Implications for the Study of Excitatory Phenomena in Neurodegenerative Diseases with Special Reference to Parkinson's Disease Michael W. Jakowec, Ph.D., The Parkinson's Institute, Sunnyvale, CA Glutamatergic Compensation after MPTP-Lesioning in Mice Un Jung Kang, M.D., University of Chicago, Chicago, IL Dopaminergic Neuronal Survival in Mice Lacking Glutathione Peroxidase Douglas A. Kerr, M.D., Ph.D., Johns Hopkins University, Baltimore, MD Role of Survival of Motor Neuron Protein in Neuronal Apoptosis of Parkinson's Disease Donald M. Kuhn, Ph.D., Wayne State University School of Medicine, Detroit, MI Tyrosine Hydroxylase as a Cytotoxic Protein in Parkinson's Disease Wei-Doing Le, M.D., Ph.D., Baylor College of Medicine, Houston, TX Nurrl Gene and Parkinson's Disease Wayne Martin, M.D., University of Alberta, Edmonton, Canada Magnetic Resonance Spectroscopy and Brain Energy Metabolism in Parkinson's Disease Uday Muthane, M.D., National Institute of Mental Health and Neurosciences, Bangalore, India; Susan E. Daniel, M.D., FRCPath, Institute of Neurology, London, England, et al Is There a Difference in Nigral Dopaminergic Neuronal Numbers Amongst Normal Individuals of Different Racial Origin? Gabriele S. Schierle, M.Sc., Wallenberg Neuroscience Centre, Lund, Sweden The Role of Excitotoxicity and Apoptosis in Cultured and Grafted Dopamine Neurons Jay S.,Schneider, Ph.D., Jefferson Medical College, Philadelphia, PA The Functional Organization of the Primate Pallidum: Targets for Gene-Based Therapy for Parkinson's Disease Michael K. Stachowiak, State University of New York at Buffalo, Amherst, NY Gene Therapy in Rat Model of Parkinson's Disease The complete list of successful candidates is being shared with our friends at the American Parkinson Disease Association and the National Parkinson Foundation, to prevent duplication with their own excellent programs of research support. Congratulations to the successful candidates and thanks to all who submitted proposals! Would that we could have funded more of them. Robin Anthony Elliott, Executive Director, Parkinson's Disease Foundation